We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Hyaluronic Acid and Vaginal Distress

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2009 by University of Messina.
Recruitment status was:  Not yet recruiting
ClinicalTrials.gov Identifier:
First Posted: April 29, 2009
Last Update Posted: April 29, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of Messina
April 27, 2009
April 29, 2009
April 29, 2009
May 2009
September 2009   (Final data collection date for primary outcome measure)
effects of the oral somministration hyaluronic acid in menopause women with vaginal distress [ Time Frame: three months ]
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
Hyaluronic Acid and Vaginal Distress
Effects of Hyaluronic Acid Oral Supplementation on the Vaginal Epithelium: a Prospective, Randomized, Double-Blind, Placebo Controlled Study
The purpose of this trial is to study the effects of the oral supplementation hyaluronic acid in menopause women with vaginal distress for treatment vaginal distress.
Not Provided
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Care Provider)
Primary Purpose: Treatment
Vaginal Disease
Other: hyaluronic acid pill
pill, 220 mg, once a day, three months
hyaluroni acid pill
Intervention: Other: hyaluronic acid pill
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
Unknown status
December 2009
September 2009   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • menopause
  • vaginal distress
  • no other therapy

Exclusion Criteria:

  • vaginal infection
  • Sjogren Syndrome
Sexes Eligible for Study: Female
45 Years to 60 Years   (Adult)
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
G.Marino University Policlinic of Messina, Menopause centre of
University of Messina
Not Provided
Principal Investigator: Tindara TL La Galia, PhD student Centre Menopause
University of Messina
April 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP